 | ||||||
| "anti diabetes" | ||||||
| WEB | ||||||
| Patent refused to Novartis on anti-diabetes formulation The Patent Office (PO) in Delhi refused to grant a patent to Novartis for a modified release formulation of the company's diabetes drug, Galvus ...
| ||||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.